Additional file 2: of Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Ungerleider, Nathan; Rao, Sonia; Shahbandi, Ashkan; Yee, Douglas; Niu, Tianhua; Frey, Wesley; Jackson, James

doi:10.6084/m9.figshare.7155671.v1

13058_2018_1044_MOESM2_ESM.pdf (1.12 MB)

Additional file 2: of Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

journal contribution

posted on 2018-10-01, 05:00 authored by Nathan Ungerleider, Sonia Rao, Ashkan Shahbandi, Douglas Yee, Tianhua Niu, Wesley Frey, James Jackson

Figure S1 Overall survival curves by PAM50 classification (for A-F) all patients from METABRIC cohort; (G-L) hormone therapy-treated patients. PAM50 classification was already determined in the METABRIC cohort and accessed through cBioportal. (PDF 1142 kb)

Funding

U.S. Department of Defense

History

Usage metrics

Keywords

TP53 Breast cancer Chemotherapy Hormone therapy Survival Senescence

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Funding

U.S. Department of Defense

History

Usage metrics

Categories

Keywords

Licence

Exports